In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™for all indicationsmatching the reference product ...

In a press release issued after market hours on February 20, Cipla announced that it has received approval for Nilotinib ...

The VAI status indicates that there are no such complying issues with the facility; hence, the USFDA will not take any regulatory or administrative action against the facility.

In addition to AVT06, which is a biosimilar candidate for Eylea ® (aflibercept) 2 mg, Alvotech is currently also developing AVT29, a biosimilar candidate for Eylea ® HD (aflibercept) 8 mg. Teva also ...

Investors have taken to punishing pharma companies that appear unable to gauge demand for their top products.

If you buy through a BGR link, we may earn an affiliate commission, helping support our expert product labs. Getting addicted, no pun intended, to an animated conspiracy thriller from Adult Swim ...

OpenAI’s big rebranding effort brings a new logo and a new typeface, OpenAI sans. OpenAI’s big rebranding effort brings a new logo and a new typeface, OpenAI sans. Emma Roth is a news writer ...

On Monday, three logos were revealed to the public, one for each potential nickname, but NHL fans weren't particularly impressed by the latest round of options. Much of the criticism was focused ...

Founded in 1935 by Khwaja Abdul Ahmeid, Cipla operates through two segments: Pharmaceuticals and New Ventures. Cipla Limited specialises in developing medications, primarily treating respiratory ...

For Cipla Ltd, the market expert suggested the ... Singh also liked Sun Pharmaceutical Industries Ltd from the pharma segment. "The counter looked good on charts. One can buy the stock with ...

During the year, the Generics Business Undertaking of the Company was transferred to Cipla Pharma and Life Sciences Limited (CPLS), wholly owned subsidiary, on a slump sale basis as a going ...

Prior to joining Cipla, he was associated with Glenmark Pharmaceuticals as EVP Business Head EMEA L. Achin was a Member of the Core Operating Group, Director on the Board of key European affiliates ...